Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX   US92532F1003

Delayed Quote. Delayed Nasdaq - 03/03 04:14:59 pm
123.52 USD   +2.79%
02/11 VERTEX PHARMACE : to Present at Upcoming Investor Conferences
02/08DJDrug Making Breaks Away From Its Old Ways
01/28 VERTEX PHARMACE : 4Q loss is deeper than expected
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/25/2015 02/26/2015 02/27/2015 03/02/2015 03/03/2015 Date
118.84(c) 119.97(c) 119.43(c) 120.17(c) 123.52(c) Last
1 651 106 1 303 281 1 050 126 1 511 228 1 533 144 Volume
+1.64% +0.95% -0.45% +0.62% +2.79% Change
More quotes
Company
Vertex Pharmaceuticals, Inc. is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs.The company's research focuses on cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune... 
Sector
Pharmaceuticals
Calendar
03/03 | 10:40amPresentation
More about the company
Surperformance© ratings of Vertex Pharmaceuticals Inc
Trading Rating : Investor Rating :
More Ratings
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Financials ($)
Sales 2015 1 092 M
EBIT 2015 -279 M
Net income 2015 -402 M
Finance 2015 570 M
Yield 2015 -
Sales 2016 2 866 M
EBIT 2016 1 238 M
Net income 2016 1 043 M
Finance 2016 1 790 M
Yield 2016 -
PER 2015 -
PER 2016 34,72
EV / Sales 2015 26,9x
EV / Sales 2016 9,81x
Capitalization 29 903 M
More Financials
Latest news on VERTEX PHARMACEUTICALS INC
02/26 VERTEX PHARMACEUTICALS : Researchers at Vertex Pharmaceuticals Release New Data ..
02/20 VERTEX PHARMACEUTICALS : to Present at Upcoming Investor Conferences
02/12 VERTEX PHARMACEUTICALS : New Findings on Medicinal Chemistry from Vertex Pharmac..
02/11 VERTEX PHARMACEUTICALS : to Present at Upcoming Investor Conferences
02/08DJDrug Making Breaks Away From Its Old Ways
02/01 DEUTSCHE BANK : Vertex Pharmaceuticals PT Raised to $155.00 at Deutsche Bank (VR..
01/28 VERTEX PHARMACEUTICALS : 4Q loss is deeper than expected
01/28 VERTEX PHARMACEUTICALS : Reports Full-Year and Fourth Quarter 2014 Financial Res..
More news
Sector news Biopharmaceuticals
01:57aDJToyota Taps First Foreign Vice President
01:47a BRISTOL MYERS SQUIBB : Announces Dividend
01:47a BRISTOL MYERS SQUIBB : U.S. Food and Drug Administration Accepts Supplemental Bi..
Plus d'actualités du secteur Biopharmaceuticals


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF